drugset / Trial / NCT01135511
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to evaluate dose-response, efficacy and safety of CP-690,550 eye drops in patients with dry eye disease.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sodium Hyaluronate | Other / unclassified | — | Topical |
| Subject | Tofacitinib | Small molecule | — | Topical |